The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.
The purpose of this project is to educate practitioners of liver-directed oncologic therapies, including surgeons and radiologists, on the theoretical advantages and clinical implications for utilizing venous embolization techniques, including portal vein and hepatic vein embolization. Given the enormous interest in these procedures and the evidence that they are needed, this book will further the understanding of those already using these procedures, will enlighten those eager to begin their utilization, and stimulate future clinical and basic research in the fascinating area of liver regeneration physiology. At present, there is no single resource on this topic such that the experiences of practitioners vary widely from institution to institution. In essence, a focused textbook would bring together many "points of view" and may help to standardize the many methodologies and approaches that will be presented. The leading experts from around the world will contribute up-to-date chapters on portal vein embolization and hepatic vein embolization. Topics that will be covered include pertinent vascular (microscopic and macroscopic) and surgical anatomy, liver regeneration (including the atrophy-hypertrophy complex), historical perspectives of major hepatic resection, various hepatobiliary surgical procedures, factors affecting hypertrophy, pathophysiology of embolization and resection, embolization techniques (including approaches and embolic agents), the indications for embolization and resection (including pre-operative volumetric and functional assessment and post-embolization follow-up), potential complications, outcomes data for different diseases, recently advocated strategies (including "definitive" treatment of hepatocellular carcinoma using portal vein embolization after transcatheter arterial chemoembolization) and future perspectives.